Wednesday August 21, 2019 02:46

Heathcare Press Release : 08 Jun 2016

Results of Clinical and Patient-Reported Outcomes Data for Baricitinib in Patients with Rheumatoid Heathcare—08 Jun 16

Eli Lilly and Company (NYSE: LLY) announced that radiographic results from a long-term extension study of baricitinib, RA-BEYOND, and patient-reported outcomes data from baricitinib's phase 3 global studies will be presented, along with other phase 2b